APO Research
Talk to an analyst

APO RESEARCH · REPORT

Disease Control and Prevention Vaccine

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Disease Control and Prevention Vaccine Industry Growth and Trends Forecast to 2032

22 December 2025123 pages

Choose your research edition.

Industry ResearchDisease Control and Prevention Vaccine Industry Research Report 2026145 pages · $2,950 USDIndustry Growth & TrendsGlobal Disease Control and Prevention Vaccine Industry Growth and Trends Forecast to 2032123 pages · $3,450 USDMarket StructureGlobal Disease Control and Prevention Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Disease Control and Prevention Vaccine Market Outlook and Growth Opportunities 2026205 pages · $4,250 USDMarket Analysis & ForecastGlobal Disease Control and Prevention Vaccine Market Analysis and Forecast 2026-2032209 pages · $4,950 USD

Market perspective

According to APO Research, the global Disease Control and Prevention Vaccine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Disease Control and Prevention Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Disease Control and Prevention Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Disease Control and Prevention Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Disease Control and Prevention Vaccine market include GSK, Takeda Pharmaceutical Company Limited, Sanofi, Johnson & Johnson, Pfizer, Daiichi Sankyo, AstraZeneca PLC, Sinovac Biotech Ltd and Serum Institute of India Pvt. Ltd, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Disease Control and Prevention Vaccine market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Disease Control and Prevention Vaccine market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Disease Control and Prevention Vaccine market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Disease Control and Prevention Vaccine.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Disease Control and Prevention Vaccine market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Disease Control and Prevention Vaccine Market by Company

GSK

Takeda Pharmaceutical Company Limited

Sanofi

Johnson & Johnson

Pfizer

Daiichi Sankyo

AstraZeneca PLC

Sinovac Biotech Ltd

Serum Institute of India Pvt. Ltd

Panacea Biotec Ltd

Novavax Inc

Mitsubishi Tanabe Pharma Corporation

Merck & Co., Inc

Inovio Pharmaceuticals Inc

Emergent BioSolutions Inc

CSL Limited

Bharat Biotech International

Bavarian Nordic A/S

Astellas Pharma Inc

Abbott Laboratories

Disease Control and Prevention Vaccine Segment by Type

Live-Attenuated

Inactivated

Recombinant Sub Unit and Toxoid

Disease Control and Prevention Vaccine Segment by Application

Pediatric Vaccine

Adult Vaccine

Disease Control and Prevention Vaccine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Disease Control and Prevention Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Disease Control and Prevention Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Disease Control and Prevention Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Disease Control and Prevention Vaccine companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Disease Control and Prevention Vaccine Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Disease Control and Prevention Vaccine Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Disease Control and Prevention Vaccine Market Share by Region (2021-2026) Table 4. Global Disease Control and Prevention Vaccine Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Disease Control and Prevention Vaccine Market Share by Region (2027-2032) Table 6. Global Disease Control and Prevention Vaccine Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Disease Control and Prevention Vaccine Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Disease Control and Prevention Vaccine Market Size Share by Type (2021-2026) Table 9. Global Disease Control and Prevention Vaccine Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Disease Control and Prevention Vaccine Market Size Share Forecasted by Type (2027-2032) Table 11. North America Disease Control and Prevention Vaccine Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Disease Control and Prevention Vaccine Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Disease Control and Prevention Vaccine Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Disease Control and Prevention Vaccine Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Disease Control and Prevention Vaccine Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Disease Control and Prevention Vaccine Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Disease Control and Prevention Vaccine Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Disease Control and Prevention Vaccine Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Disease Control and Prevention Vaccine Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Disease Control and Prevention Vaccine Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Disease Control and Prevention Vaccine Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Disease Control and Prevention Vaccine Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Disease Control and Prevention Vaccine Market Size Share by Application (2021-2026) Table 24. Global Disease Control and Prevention Vaccine Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Disease Control and Prevention Vaccine Market Size Share Forecasted by Application (2027-2032) Table 26. North America Disease Control and Prevention Vaccine Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Disease Control and Prevention Vaccine Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Disease Control and Prevention Vaccine Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Disease Control and Prevention Vaccine Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Disease Control and Prevention Vaccine Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Disease Control and Prevention Vaccine Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Disease Control and Prevention Vaccine Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Disease Control and Prevention Vaccine Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Disease Control and Prevention Vaccine Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Disease Control and Prevention Vaccine Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Disease Control and Prevention Vaccine Industry Trends Table 37. Disease Control and Prevention Vaccine Industry Drivers Table 38. Disease Control and Prevention Vaccine Industry Opportunities and Challenges Table 39. Disease Control and Prevention Vaccine Industry Restraints Table 40. Global Disease Control and Prevention Vaccine Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Disease Control and Prevention Vaccine Revenue Market Share by Company (2021-2026) Table 42. Global Disease Control and Prevention Vaccine Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Disease Control and Prevention Vaccine Key Company Headquarters & Area Served Table 44. Global Disease Control and Prevention Vaccine Company, Product Type & Application Table 45. Global Disease Control and Prevention Vaccine Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Disease Control and Prevention Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. GSK Company Information Table 49. GSK Business Overview Table 50. GSK Disease Control and Prevention Vaccine Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. GSK Disease Control and Prevention Vaccine Product Portfolio Table 52. GSK Recent Development Table 53. Takeda Pharmaceutical Company Limited Company Information Table 54. Takeda Pharmaceutical Company Limited Business Overview Table 55. Takeda Pharmaceutical Company Limited Disease Control and Prevention Vaccine Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Takeda Pharmaceutical Company Limited Disease Control and Prevention Vaccine Product Portfolio Table 57. Takeda Pharmaceutical Company Limited Recent Development Table 58. Sanofi Company Information Table 59. Sanofi Business Overview Table 60. Sanofi Disease Control and Prevention Vaccine Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Sanofi Disease Control and Prevention Vaccine Product Portfolio Table 62. Sanofi Recent Development Table 63. Johnson & Johnson Company Information Table 64. Johnson & Johnson Business Overview Table 65. Johnson & Johnson Disease Control and Prevention Vaccine Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Johnson & Johnson Disease Control and Prevention Vaccine Product Portfolio Table 67. Johnson & Johnson Recent Development Table 68. Pfizer Company Information Table 69. Pfizer Business Overview Table 70. Pfizer Disease Control and Prevention Vaccine Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Pfizer Disease Control and Prevention Vaccine Product Portfolio Table 72. Pfizer Recent Development Table 73. Daiichi Sankyo Company Information Table 74. Daiichi Sankyo Business Overview Table 75. Daiichi Sankyo Disease Control and Prevention Vaccine Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Daiichi Sankyo Disease Control and Prevention Vaccine Product Portfolio Table 77. Daiichi Sankyo Recent Development Table 78. AstraZeneca PLC Company Information Table 79. AstraZeneca PLC Business Overview Table 80. AstraZeneca PLC Disease Control and Prevention Vaccine Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. AstraZeneca PLC Disease Control and Prevention Vaccine Product Portfolio Table 82. AstraZeneca PLC Recent Development Table 83. Sinovac Biotech Ltd Company Information Table 84. Sinovac Biotech Ltd Business Overview Table 85. Sinovac Biotech Ltd Disease Control and Prevention Vaccine Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Sinovac Biotech Ltd Disease Control and Prevention Vaccine Product Portfolio Table 87. Sinovac Biotech Ltd Recent Development Table 88. Serum Institute of India Pvt. Ltd Company Information Table 89. Serum Institute of India Pvt. Ltd Business Overview Table 90. Serum Institute of India Pvt. Ltd Disease Control and Prevention Vaccine Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. Serum Institute of India Pvt. Ltd Disease Control and Prevention Vaccine Product Portfolio Table 92. Serum Institute of India Pvt. Ltd Recent Development Table 93. Panacea Biotec Ltd Company Information Table 94. Panacea Biotec Ltd Business Overview Table 95. Panacea Biotec Ltd Disease Control and Prevention Vaccine Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. Panacea Biotec Ltd Disease Control and Prevention Vaccine Product Portfolio Table 97. Panacea Biotec Ltd Recent Development Table 98. Novavax Inc Company Information Table 99. Novavax Inc Business Overview Table 100. Novavax Inc Disease Control and Prevention Vaccine Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. Novavax Inc Disease Control and Prevention Vaccine Product Portfolio Table 102. Novavax Inc Recent Development Table 103. Mitsubishi Tanabe Pharma Corporation Company Information Table 104. Mitsubishi Tanabe Pharma Corporation Business Overview Table 105. Mitsubishi Tanabe Pharma Corporation Disease Control and Prevention Vaccine Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. Mitsubishi Tanabe Pharma Corporation Disease Control and Prevention Vaccine Product Portfolio Table 107. Mitsubishi Tanabe Pharma Corporation Recent Development Table 108. Merck & Co., Inc Company Information Table 109. Merck & Co., Inc Business Overview Table 110. Merck & Co., Inc Disease Control and Prevention Vaccine Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. Merck & Co., Inc Disease Control and Prevention Vaccine Product Portfolio Table 112. Merck & Co., Inc Recent Development Table 113. Inovio Pharmaceuticals Inc Company Information Table 114. Inovio Pharmaceuticals Inc Business Overview Table 115. Inovio Pharmaceuticals Inc Disease Control and Prevention Vaccine Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. Inovio Pharmaceuticals Inc Disease Control and Prevention Vaccine Product Portfolio Table 117. Inovio Pharmaceuticals Inc Recent Development Table 118. Emergent BioSolutions Inc Company Information Table 119. Emergent BioSolutions Inc Business Overview Table 120. Emergent BioSolutions Inc Disease Control and Prevention Vaccine Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 121. Emergent BioSolutions Inc Disease Control and Prevention Vaccine Product Portfolio Table 122. Emergent BioSolutions Inc Recent Development Table 123. CSL Limited Company Information Table 124. CSL Limited Business Overview Table 125. CSL Limited Disease Control and Prevention Vaccine Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 126. CSL Limited Disease Control and Prevention Vaccine Product Portfolio Table 127. CSL Limited Recent Development Table 128. Bharat Biotech International Company Information Table 129. Bharat Biotech International Business Overview Table 130. Bharat Biotech International Disease Control and Prevention Vaccine Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 131. Bharat Biotech International Disease Control and Prevention Vaccine Product Portfolio Table 132. Bharat Biotech International Recent Development Table 133. Bavarian Nordic A/S Company Information Table 134. Bavarian Nordic A/S Business Overview Table 135. Bavarian Nordic A/S Disease Control and Prevention Vaccine Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 136. Bavarian Nordic A/S Disease Control and Prevention Vaccine Product Portfolio Table 137. Bavarian Nordic A/S Recent Development Table 138. Astellas Pharma Inc Company Information Table 139. Astellas Pharma Inc Business Overview Table 140. Astellas Pharma Inc Disease Control and Prevention Vaccine Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 141. Astellas Pharma Inc Disease Control and Prevention Vaccine Product Portfolio Table 142. Astellas Pharma Inc Recent Development Table 143. Abbott Laboratories Company Information Table 144. Abbott Laboratories Business Overview Table 145. Abbott Laboratories Disease Control and Prevention Vaccine Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 146. Abbott Laboratories Disease Control and Prevention Vaccine Product Portfolio Table 147. Abbott Laboratories Recent Development Table 148. North America Disease Control and Prevention Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 149. North America Disease Control and Prevention Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 150. North America Disease Control and Prevention Vaccine Market Share by Country (2021-2026) Table 151. North America Disease Control and Prevention Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 152. North America Disease Control and Prevention Vaccine Market Share Forecast by Country (2027-2032) Table 153. Europe Disease Control and Prevention Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 154. Europe Disease Control and Prevention Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 155. Europe Disease Control and Prevention Vaccine Market Share by Country (2021-2026) Table 156. Europe Disease Control and Prevention Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 157. Europe Disease Control and Prevention Vaccine Market Share Forecast by Country (2027-2032) Table 158. Asia-Pacific Disease Control and Prevention Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 159. Asia-Pacific Disease Control and Prevention Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 160. Asia-Pacific Disease Control and Prevention Vaccine Market Share by Country (2021-2026) Table 161. Asia-Pacific Disease Control and Prevention Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 162. Asia-Pacific Disease Control and Prevention Vaccine Market Share Forecast by Country (2027-2032) Table 163. Latin America Disease Control and Prevention Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 164. Latin America Disease Control and Prevention Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 165. Latin America Disease Control and Prevention Vaccine Market Share by Country (2021-2026) Table 166. Latin America Disease Control and Prevention Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 167. Latin America Disease Control and Prevention Vaccine Market Share Forecast by Country (2027-2032) Table 168. Middle East & Africa Disease Control and Prevention Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 169. Middle East & Africa Disease Control and Prevention Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 170. Middle East & Africa Disease Control and Prevention Vaccine Market Share by Country (2021-2026) Table 171. Middle East & Africa Disease Control and Prevention Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 172. Middle East & Africa Disease Control and Prevention Vaccine Market Share Forecast by Country (2027-2032) Table 173. Research Programs/Design for This Report Table 174. Authors List of This Report Table 175. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Disease Control and Prevention Vaccine Product Image Figure 3. Global Disease Control and Prevention Vaccine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Disease Control and Prevention Vaccine Market Size (2021-2032) & (US$ Million) Figure 5. Global Disease Control and Prevention Vaccine Market Share by Region: 2025 VS 2032 Figure 6. Global Disease Control and Prevention Vaccine Market Share by Region (2021-2032) Figure 7. North America Disease Control and Prevention Vaccine Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Disease Control and Prevention Vaccine Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Disease Control and Prevention Vaccine Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Disease Control and Prevention Vaccine Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Disease Control and Prevention Vaccine Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Live-Attenuated Image Figure 13. Global Live-Attenuated Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Inactivated Image Figure 15. Global Inactivated Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Recombinant Sub Unit and Toxoid Image Figure 17. Global Recombinant Sub Unit and Toxoid Market Size YoY Growth (2021-2032) & (US$ Million) Figure 18. Global Disease Control and Prevention Vaccine Market Size Overview by Type (2021-2032) & (US$ Million) Figure 19. Global Disease Control and Prevention Vaccine Market Share by Type 2025 VS 2032 Figure 20. North America Disease Control and Prevention Vaccine Market Size Share by Type (2021-2032) Figure 21. Europe Disease Control and Prevention Vaccine Market Size Share by Type (2021-2032) Figure 22. Asia-Pacific Disease Control and Prevention Vaccine Market Size Share by Type (2021-2032) Figure 23. Latin America Disease Control and Prevention Vaccine Market Size Share by Type (2021-2032) Figure 24. Middle East and Africa Disease Control and Prevention Vaccine Market Size Share by Type (2021-2032) Figure 25. Pediatric Vaccine Image Figure 26. Global Pediatric Vaccine Market Size YoY Growth (2021-2032) & (US$ Million) Figure 27. Adult Vaccine Image Figure 28. Global Adult Vaccine Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Global Disease Control and Prevention Vaccine Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Disease Control and Prevention Vaccine Market Share by Application 2025 VS 2032 Figure 31. North America Disease Control and Prevention Vaccine Market Size Share by Application (2021-2032) Figure 32. Europe Disease Control and Prevention Vaccine Market Size Share by Application (2021-2032) Figure 33. Asia-Pacific Disease Control and Prevention Vaccine Market Size Share by Application (2021-2032) Figure 34. Latin America Disease Control and Prevention Vaccine Market Size Share by Application (2021-2032) Figure 35. Middle East and Africa Disease Control and Prevention Vaccine Market Size Share by Application (2021-2032) Figure 36. Global Top 5 and 10 Disease Control and Prevention Vaccine Players Market Share by Revenue in 2025 Figure 37. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 38. North America Disease Control and Prevention Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 39. North America Disease Control and Prevention Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 40. North America Disease Control and Prevention Vaccine Market Share by Country (2021-2032) Figure 41. Europe Disease Control and Prevention Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. Europe Disease Control and Prevention Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Disease Control and Prevention Vaccine Market Share by Country (2021-2032) Figure 44. Asia-Pacific Disease Control and Prevention Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 45. Asia-Pacific Disease Control and Prevention Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 46. Asia-Pacific Disease Control and Prevention Vaccine Market Share by Country (2021-2032) Figure 47. Latin America Disease Control and Prevention Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Latin America Disease Control and Prevention Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Latin America Disease Control and Prevention Vaccine Market Share by Country (2021-2032) Figure 50. Middle East & Africa Disease Control and Prevention Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 51. Middle East & Africa Disease Control and Prevention Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 52. Middle East & Africa Disease Control and Prevention Vaccine Market Share by Country (2021-2032) Figure 53. Years Considered Figure 54. Research Process Figure 55. Key Executives Interviewed

Scope & coverage.

Types
  • Live-Attenuated
  • Inactivated
  • Recombinant Sub Unit and Toxoid
Applications
  • Pediatric Vaccine
  • Adult Vaccine
Companies covered
  • GSK
  • Takeda Pharmaceutical Company Limited
  • Sanofi
  • Johnson & Johnson
  • Pfizer
  • Daiichi Sankyo
  • AstraZeneca PLC
  • Sinovac Biotech Ltd
  • Serum Institute of India Pvt. Ltd
  • Panacea Biotec Ltd
  • Novavax Inc
  • Mitsubishi Tanabe Pharma Corporation
  • Merck & Co., Inc
  • Inovio Pharmaceuticals Inc
  • Emergent BioSolutions Inc
  • CSL Limited
  • Bharat Biotech International
  • Bavarian Nordic A/S
  • Astellas Pharma Inc
  • Abbott Laboratories

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Disease Control and Prevention Vaccine Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Disease Control and Prevention Vaccine Market Size by Region (2021-2032)
  5. 1.4.1 Global Disease Control and Prevention Vaccine Market Size by Region (2021-2026)
  6. 1.4.2 Global Disease Control and Prevention Vaccine Market Size by Region (2027-2032)
  7. 1.5 Key Regions Disease Control and Prevention Vaccine Market Size (2021-2032)
  8. 1.5.1 North America Disease Control and Prevention Vaccine Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Disease Control and Prevention Vaccine Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Disease Control and Prevention Vaccine Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Disease Control and Prevention Vaccine Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Disease Control and Prevention Vaccine Market Size Growth Rate (2021-2032)
2 Disease Control and Prevention Vaccine Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Live-Attenuated
  3. 2.1.2 Inactivated
  4. 2.1.3 Recombinant Sub Unit and Toxoid
  5. 2.2 Global Disease Control and Prevention Vaccine Market Size by Type
  6. 2.2.1 Global Disease Control and Prevention Vaccine Market Size Overview by Type (2021-2032)
  7. 2.2.2 Global Disease Control and Prevention Vaccine Historic Market Size Review by Type (2021-2026)
  8. 2.2.3 Global Disease Control and Prevention Vaccine Market Size Forecasted by Type (2027-2032)
  9. 2.3 Global Disease Control and Prevention Vaccine Market Size by Regions
  10. 2.3.1 North America Disease Control and Prevention Vaccine Market Size Breakdown by Type (2021-2026)
  11. 2.3.2 Europe Disease Control and Prevention Vaccine Market Size Breakdown by Type (2021-2026)
  12. 2.3.3 Asia-Pacific Disease Control and Prevention Vaccine Market Size Breakdown by Type (2021-2026)
  13. 2.3.4 South America Disease Control and Prevention Vaccine Market Size Breakdown by Type (2021-2026)
  14. 2.3.5 Middle East and Africa Disease Control and Prevention Vaccine Market Size Breakdown by Type (2021-2026)
3 Disease Control and Prevention Vaccine Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Pediatric Vaccine
  3. 3.1.2 Adult Vaccine
  4. 3.2 Global Disease Control and Prevention Vaccine Market Size by Application
  5. 3.2.1 Global Disease Control and Prevention Vaccine Market Size Overview by Application (2021-2032)
  6. 3.2.2 Global Disease Control and Prevention Vaccine Historic Market Size Review by Application (2021-2026)
  7. 3.2.3 Global Disease Control and Prevention Vaccine Market Size Forecasted by Application (2027-2032)
  8. 3.3 Global Disease Control and Prevention Vaccine Market Size by Regions
  9. 3.3.1 North America Disease Control and Prevention Vaccine Market Size Breakdown by Application (2021-2026)
  10. 3.3.2 Europe Disease Control and Prevention Vaccine Market Size Breakdown by Application (2021-2026)
  11. 3.3.3 Asia-Pacific Disease Control and Prevention Vaccine Market Size Breakdown by Application (2021-2026)
  12. 3.3.4 South America Disease Control and Prevention Vaccine Market Size Breakdown by Application (2021-2026)
  13. 3.3.5 Middle East and Africa Disease Control and Prevention Vaccine Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Disease Control and Prevention Vaccine Industry Trends
  2. 4.2 Disease Control and Prevention Vaccine Industry Drivers
  3. 4.3 Disease Control and Prevention Vaccine Industry Opportunities and Challenges
  4. 4.4 Disease Control and Prevention Vaccine Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Disease Control and Prevention Vaccine Revenue (2021-2026)
  2. 5.2 Global Disease Control and Prevention Vaccine Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Disease Control and Prevention Vaccine Key Company Headquarters & Area Served
  4. 5.4 Global Disease Control and Prevention Vaccine Company, Product Type & Application
  5. 5.5 Global Disease Control and Prevention Vaccine Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Disease Control and Prevention Vaccine Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Disease Control and Prevention Vaccine Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Disease Control and Prevention Vaccine Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 GSK
  2. 6.1.1 GSK Company Information
  3. 6.1.2 GSK Business Overview
  4. 6.1.3 GSK Disease Control and Prevention Vaccine Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 GSK Disease Control and Prevention Vaccine Product Portfolio
  6. 6.1.5 GSK Recent Developments
  7. 6.2 Takeda Pharmaceutical Company Limited
  8. 6.2.1 Takeda Pharmaceutical Company Limited Company Information
  9. 6.2.2 Takeda Pharmaceutical Company Limited Business Overview
  10. 6.2.3 Takeda Pharmaceutical Company Limited Disease Control and Prevention Vaccine Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Takeda Pharmaceutical Company Limited Disease Control and Prevention Vaccine Product Portfolio
  12. 6.2.5 Takeda Pharmaceutical Company Limited Recent Developments
  13. 6.3 Sanofi
  14. 6.3.1 Sanofi Company Information
  15. 6.3.2 Sanofi Business Overview
  16. 6.3.3 Sanofi Disease Control and Prevention Vaccine Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Sanofi Disease Control and Prevention Vaccine Product Portfolio
  18. 6.3.5 Sanofi Recent Developments
  19. 6.4 Johnson & Johnson
  20. 6.4.1 Johnson & Johnson Company Information
  21. 6.4.2 Johnson & Johnson Business Overview
  22. 6.4.3 Johnson & Johnson Disease Control and Prevention Vaccine Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Johnson & Johnson Disease Control and Prevention Vaccine Product Portfolio
  24. 6.4.5 Johnson & Johnson Recent Developments
  25. 6.5 Pfizer
  26. 6.5.1 Pfizer Company Information
  27. 6.5.2 Pfizer Business Overview
  28. 6.5.3 Pfizer Disease Control and Prevention Vaccine Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Pfizer Disease Control and Prevention Vaccine Product Portfolio
  30. 6.5.5 Pfizer Recent Developments
  31. 6.6 Daiichi Sankyo
  32. 6.6.1 Daiichi Sankyo Company Information
  33. 6.6.2 Daiichi Sankyo Business Overview
  34. 6.6.3 Daiichi Sankyo Disease Control and Prevention Vaccine Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Daiichi Sankyo Disease Control and Prevention Vaccine Product Portfolio
  36. 6.6.5 Daiichi Sankyo Recent Developments
  37. 6.7 AstraZeneca PLC
  38. 6.7.1 AstraZeneca PLC Company Information
  39. 6.7.2 AstraZeneca PLC Business Overview
  40. 6.7.3 AstraZeneca PLC Disease Control and Prevention Vaccine Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 AstraZeneca PLC Disease Control and Prevention Vaccine Product Portfolio
  42. 6.7.5 AstraZeneca PLC Recent Developments
  43. 6.8 Sinovac Biotech Ltd
  44. 6.8.1 Sinovac Biotech Ltd Company Information
  45. 6.8.2 Sinovac Biotech Ltd Business Overview
  46. 6.8.3 Sinovac Biotech Ltd Disease Control and Prevention Vaccine Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Sinovac Biotech Ltd Disease Control and Prevention Vaccine Product Portfolio
  48. 6.8.5 Sinovac Biotech Ltd Recent Developments
  49. 6.9 Serum Institute of India Pvt. Ltd
  50. 6.9.1 Serum Institute of India Pvt. Ltd Company Information
  51. 6.9.2 Serum Institute of India Pvt. Ltd Business Overview
  52. 6.9.3 Serum Institute of India Pvt. Ltd Disease Control and Prevention Vaccine Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 Serum Institute of India Pvt. Ltd Disease Control and Prevention Vaccine Product Portfolio
  54. 6.9.5 Serum Institute of India Pvt. Ltd Recent Developments
  55. 6.10 Panacea Biotec Ltd
  56. 6.10.1 Panacea Biotec Ltd Company Information
  57. 6.10.2 Panacea Biotec Ltd Business Overview
  58. 6.10.3 Panacea Biotec Ltd Disease Control and Prevention Vaccine Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 Panacea Biotec Ltd Disease Control and Prevention Vaccine Product Portfolio
  60. 6.10.5 Panacea Biotec Ltd Recent Developments
  61. 6.11 Novavax Inc
  62. 6.11.1 Novavax Inc Company Information
  63. 6.11.2 Novavax Inc Business Overview
  64. 6.11.3 Novavax Inc Disease Control and Prevention Vaccine Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 Novavax Inc Disease Control and Prevention Vaccine Product Portfolio
  66. 6.11.5 Novavax Inc Recent Developments
  67. 6.12 Mitsubishi Tanabe Pharma Corporation
  68. 6.12.1 Mitsubishi Tanabe Pharma Corporation Company Information
  69. 6.12.2 Mitsubishi Tanabe Pharma Corporation Business Overview
  70. 6.12.3 Mitsubishi Tanabe Pharma Corporation Disease Control and Prevention Vaccine Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 Mitsubishi Tanabe Pharma Corporation Disease Control and Prevention Vaccine Product Portfolio
  72. 6.12.5 Mitsubishi Tanabe Pharma Corporation Recent Developments
  73. 6.13 Merck & Co., Inc
  74. 6.13.1 Merck & Co., Inc Company Information
  75. 6.13.2 Merck & Co., Inc Business Overview
  76. 6.13.3 Merck & Co., Inc Disease Control and Prevention Vaccine Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 Merck & Co., Inc Disease Control and Prevention Vaccine Product Portfolio
  78. 6.13.5 Merck & Co., Inc Recent Developments
  79. 6.14 Inovio Pharmaceuticals Inc
  80. 6.14.1 Inovio Pharmaceuticals Inc Company Information
  81. 6.14.2 Inovio Pharmaceuticals Inc Business Overview
  82. 6.14.3 Inovio Pharmaceuticals Inc Disease Control and Prevention Vaccine Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 Inovio Pharmaceuticals Inc Disease Control and Prevention Vaccine Product Portfolio
  84. 6.14.5 Inovio Pharmaceuticals Inc Recent Developments
  85. 6.15 Emergent BioSolutions Inc
  86. 6.15.1 Emergent BioSolutions Inc Company Information
  87. 6.15.2 Emergent BioSolutions Inc Business Overview
  88. 6.15.3 Emergent BioSolutions Inc Disease Control and Prevention Vaccine Revenue, Global Share and Gross Margin (2021-2026)
  89. 6.15.4 Emergent BioSolutions Inc Disease Control and Prevention Vaccine Product Portfolio
  90. 6.15.5 Emergent BioSolutions Inc Recent Developments
  91. 6.16 CSL Limited
  92. 6.16.1 CSL Limited Company Information
  93. 6.16.2 CSL Limited Business Overview
  94. 6.16.3 CSL Limited Disease Control and Prevention Vaccine Revenue, Global Share and Gross Margin (2021-2026)
  95. 6.16.4 CSL Limited Disease Control and Prevention Vaccine Product Portfolio
  96. 6.16.5 CSL Limited Recent Developments
  97. 6.17 Bharat Biotech International
  98. 6.17.1 Bharat Biotech International Company Information
  99. 6.17.2 Bharat Biotech International Business Overview
  100. 6.17.3 Bharat Biotech International Disease Control and Prevention Vaccine Revenue, Global Share and Gross Margin (2021-2026)
  101. 6.17.4 Bharat Biotech International Disease Control and Prevention Vaccine Product Portfolio
  102. 6.17.5 Bharat Biotech International Recent Developments
  103. 6.18 Bavarian Nordic A/S
  104. 6.18.1 Bavarian Nordic A/S Company Information
  105. 6.18.2 Bavarian Nordic A/S Business Overview
  106. 6.18.3 Bavarian Nordic A/S Disease Control and Prevention Vaccine Revenue, Global Share and Gross Margin (2021-2026)
  107. 6.18.4 Bavarian Nordic A/S Disease Control and Prevention Vaccine Product Portfolio
  108. 6.18.5 Bavarian Nordic A/S Recent Developments
  109. 6.19 Astellas Pharma Inc
  110. 6.19.1 Astellas Pharma Inc Company Information
  111. 6.19.2 Astellas Pharma Inc Business Overview
  112. 6.19.3 Astellas Pharma Inc Disease Control and Prevention Vaccine Revenue, Global Share and Gross Margin (2021-2026)
  113. 6.19.4 Astellas Pharma Inc Disease Control and Prevention Vaccine Product Portfolio
  114. 6.19.5 Astellas Pharma Inc Recent Developments
  115. 6.20 Abbott Laboratories
  116. 6.20.1 Abbott Laboratories Company Information
  117. 6.20.2 Abbott Laboratories Business Overview
  118. 6.20.3 Abbott Laboratories Disease Control and Prevention Vaccine Revenue, Global Share and Gross Margin (2021-2026)
  119. 6.20.4 Abbott Laboratories Disease Control and Prevention Vaccine Product Portfolio
  120. 6.20.5 Abbott Laboratories Recent Developments
7 North America
  1. 7.1 North America Disease Control and Prevention Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Disease Control and Prevention Vaccine Market Size by Country (2021-2026)
  3. 7.3 North America Disease Control and Prevention Vaccine Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Disease Control and Prevention Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Disease Control and Prevention Vaccine Market Size by Country (2021-2026)
  3. 8.3 Europe Disease Control and Prevention Vaccine Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Disease Control and Prevention Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Disease Control and Prevention Vaccine Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Disease Control and Prevention Vaccine Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Disease Control and Prevention Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Disease Control and Prevention Vaccine Market Size by Country (2021-2026)
  3. 10.3 South America Disease Control and Prevention Vaccine Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Disease Control and Prevention Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Disease Control and Prevention Vaccine Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Disease Control and Prevention Vaccine Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst